Drug or treatment

Frexalimab clinical trials

As of November 12, 2026, Find a Trial lists 3 clinical trials of Frexalimab that are recruiting, at sites in 28 countries (most in Brazil (3), China (3), Italy (3)). By phase: Phase 3 (1), Phase 2 (1), Phase 2/3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest trials

StudyPhaseWhereStatusRegistered
Frexalimab versus tacrolimus to prevent kidney transplant rejection Phase 2/3 San Francisco, California and 72 other locations Recruiting Feb 17, 2026
Comparing under-the-skin versus intravenous frexalimab for adults with multiple sclerosis Phase 3 Cullman, Alabama and 67 other locations Recruiting Jan 8, 2026
Evaluating treatments for kidney diseases in young to middle-aged adults Phase 2 Birmingham, Alabama and 78 other locations Recruiting Jul 15, 2024

All recruiting trials (3)

Quick answers

How many clinical trials of Frexalimab are recruiting right now?

3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 28 countries. The most sites are in Brazil (3 trials), China (3 trials), Italy (3 trials), Spain (3 trials), United States (3 trials). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 3: 1, Phase 2: 1, Phase 2/3: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.